Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
Webcast
Continuing from Part 1, this short session updates supply chain professionals on the design and timing of the new small bore tubing connectors maki
Podcasts
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re
On-Demand Educational Webinars
This session explains the benefits of implementing the UDI such as immediate device status updates through collaboration with manufacturers and…
On-Demand Educational Webinars
Today, health systems are being forced to leverage disparate data from internal and external sources to drive business intelligence solutions. In…
Advisory
EtO Quality Advisory
Overview:
The AHA and AHRMM have released a Quality Advisory on ethylene oxide sterilization of medical de
On-Demand Educational Webinars
The rapid advancement of barcode scanning and RFID technologies coupled with improved interoperability has enabled a new level of data analytics that…